Market Cap

Kyongbo Pharmaceutical Co. Ltd Market Capitalization:

₩136.27 Billion

KRW as of Jan. 1, 2026

US$94.5 Million

business Kyongbo Pharmaceutical Co. Ltd Company Profile

Kyongbo Pharmaceutical Co. Ltd Main Stock Listing

KRX: 214390

Market Capitalization History of Kyongbo Pharmaceutical Co. Ltd

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Top Competitors by Market Capitalization

Industry: Drug Manufacturers—Specialty & Generic
Company Market Cap (USD)
MERCK Kommanditgesellschaft auf Aktien $62.01 B
Zoetis Inc. $55.81 B
Takeda Pharmaceutical Company Limited $45.42 B
Haleon plc $44.50 B
Teva Pharmaceutical Industries Limited $35.85 B
Sector: Healthcare
Company Market Cap (USD)
Lilly $968.50 B
Johnson & Johnson $499.57 B
AbbVie $405.28 B
Roche $332.12 B
UnitedHealth Group $304.72 B

Yearly evolution of Kyongbo Pharmaceutical Co. Ltd market cap

Date Market Cap YoY Change
Jan. 1, 2026 ₩136.27 B -13.11%
Jan. 1, 2025 ₩156.83 B -19.01%
Jan. 1, 2024 ₩193.65 B 0.87%
Jan. 1, 2023 ₩191.97 B -4.96%
Jan. 1, 2022 ₩201.99 B -41.18%
Jan. 1, 2021 ₩343.40 B 72.25%
Jan. 1, 2020 ₩199.37 B -20.38%
Jan. 1, 2019 ₩250.40 B -29.29%
Jan. 1, 2018 ₩354.14 B 14.23%
Jan. 1, 2017 ₩310.02 B -23.53%
Jan. 1, 2016 ₩405.41 B

Market capitalization is calculated from the opening stock price at the beginning of each year.

Kyongbo Pharmaceutical Co. Ltd Categories

South Korea languages Healthcare languages Drug Manufacturers—Specialty & Generic
South Korea Healthcare South Korea Drug Manufacturers—Specialty & Generic

Stocks & Indices

Kyongbo Pharmaceutical Co. Ltd has the following listings and related stock indices.


Stock: KRX: 214390

What is a company's market capitalization?

The market capitalization of a company, more simply referred to as "market cap", is the total market value of a publicly traded company's outstanding shares. It is often considered as a key indicator of what a company is worth.